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Atopic dermatitis (AD) is a chronic dermatological condition 
with increasing prevalence, which is becoming a major social 
issue.1 Since the disease poses great economic burden and has 
a negative impact on the patient’s daily life,2 long-term national 
treatment plans should be considered.3
A deluge of scientifically unconfirmed information from the 
media and alternative medicine can cause patient to misun-
derstand AD.4,5 Moreover, fear of medical therapy may also 
lead to inappropriate treatment.6 Therefore, providing proper 
education to patients and their caregivers is important in im-
Current Status of Patient Education in the Management 
of Atopic Dermatitis in Korea
Min Kyung Lee1, Ju-Hee Seo2, Howard Chu1, Hyunjung Kim3, Yong Hyun Jang4, Jae Won Jeong5, 
Hye Yung Yum6, Man Yong Han7, Ho Joo Yoon8, Sang-Heon Cho9, Yeong Ho Rha10, Jin-Tack Kim11, 
Young Lip Park12, Seong Jun Seo13, Kwang Hoon Lee1, and Chang Ook Park1
1Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul; 
2Department of Pediatrics, Dankook University Hospital, Cheonan; 
3Department of Dermatology, Atopy Clinic, Seoul Medical Center, Seoul; 
4Department of Dermatology, School of Medicine, Kyungpook National University, Daegu; 
5Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang; 
6Department of Pediatrics, Atopy Clinic, Seoul Medical Center, Seoul; 
7Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam; 
8Department of Internal Medicine, Hanyang University College of Medicine, Seoul; 
9Department of Internal Medicine, Seoul National University College of Medicine, Seoul; 
10Department of Pediatrics, School of Medicine, Kyung Hee University, Seoul; 
11Department of Pediatrics, College of Medicine, the Catholic University of Korea, Seoul; 
12Department of Dermatology, Soonchunhyang University College of Medicine, Seoul; 
13Department of Dermatology, Chung-Ang University Hospital, Seoul, Korea.
Patient education is important for successful management of atopic dermatitis; however, due to limited time and resources, patient 
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naires, and 26.8% indicated that they have had separate educational programs. The workforce involved in the educational program 
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characteristics and natural course of atopic dermatitis and environmental management. Overall, 96.7% of the participants replied 
that an additional charge is needed for education; moreover, additional assistance from an academic society or association, in the 
form of medical staff, organized data, and advertisement, is required to develop and provide a well-structured educational pro-
gram. A standardized education protocol will effectively provide appropriate education for patients with atopic dermatitis. Ar-
rangement of education fees, covered by the National Health Insurance Service, will lead to the establishment of a structured edu-
cational program and participation of an additional medical workforce.
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proving the patient’s attitude toward the disease, which may 
ensure better treatment compliance, and eventually the over-
all treatment response.7-10 
Although previous studies in Korea have demonstrated the 
need for education on AD,11 no study has assessed how the ed-
ucational programs are provided. In this study, we adminis-
tered a questionnaire to clinicians who currently treat patients 
with AD in Korea. Through this study, we aimed to assess the 
education status on AD and utilize the results as a foundation 
for the future development of a standardized educational pro-
gram in Korea.
A survey was conducted between June and September 2017 
via email to all clinicians registered with the Korean Dermato-
logical Association (KDA); Korean Academy of Pediatric Aller-
gy and Respiratory Disease (KAPARD); and Korean Academy of 
Asthma, Allergy, and Clinical Immunology (KAAACI), em-
ployed at various centers. This study was approved by the Insti-
tutional Review Board of Severance Hospital (IRB no. 4-2018-
1018).
The questionnaire comprised of 22 questions, largely cate-
gorized under the following topics: 1) workplace; 2) presence 
of an educational program; 3) methodology used for the pro-
grams; and 4) necessary conditions for the implementation of 
programs. 
The survey was sent via e-mail to 3420 clinicians, and 153 of 
them (44 dermatologists and 109 pediatric allergists or aller-
gists) responded (Table 1). The average clinical experience 
duration was 17.88 years. Forty-eight participants (31.4%) 
were from primary private clinics, 22 (14.4%) were from sec-
ondary medical centers, and 82 (53.6%) were from tertiary 
centers (university hospitals). Clinicians reported the follow-
ing consultation times: 14 participants (9.2%), ≤5 min; 56 par-
ticipants (36.6%), 6–10 min; 55 participants (35.9%), 11–20 
min; and 28 participants (18.3%), 21–30 min. No clinician 
spent longer than 30 min per patient. When asked about the 
ideal duration for education, among the 90 participants who 
responded, 43 participants (47.8%) indicated 15–30 min and 24 
(26.7%) indicated 30–60 min to be preferable. Several respond-
ed that ≤15 min or ≥60 min would be needed [21/90 (23.3%) 
and 2/90 (2.2%), respectively].
We then assessed if any additional educational programs 
were provided. Among the 153 participants, 41 (26.8%) said a 
separate program was provided. Most of these responders 
were from university hospitals (30 participants), followed by 
secondary medical centers (seven participants), private clinics 
(three participants), and children’s hospitals (two participants). 
Regarding the program, 33 of 41 participating clinicians (80.5%) 
provided an individual-level educational program, and four 
(9.7%) provided a group-level program. The remaining partic-
ipants (9.7%) provided both individual- and group-level pro-
grams (Table 2).
We asked a different set of questions to the 37 clinicians 
who provided individual-level educational programs. Educa-
tion was most often provided at the outpatient clinic (73%), 
whereas in some cases, a separate consultation room was used 
(27.6%). In very few cases, either a treatment room or a special 
information center was used. Group-level programs were of-
fered at various venues, including an outpatient clinic, consul-
tation room, hospital auditorium, and patient ward (Table 2). 
Among the workforce involved in individual-level programs 
(multiple answers allowed), nurses were found to be most fre-
Table 2. Responses Regarding Individual and Group Education
Individual 
education
Group 
education
Both
Types of medical center*
Primary clinic    1 (2.7) 2 (25) -
Children’s hospital    2 (5.4) - -
Secondary hospital      6 (16.2)    1 (12.5) 1 (25)
University hospital    28 (75.7)    5 (62.5) 3 (75)
Venue for education
Outpatient clinic 27 (73) 2 (25) -
Counseling office      8 (21.6) 2 (25) -
Others†    2 (5.4) 4 (50) -
Medical staff providing the education‡
Nurses    23 (62.2)    8 (47.1) -
Residents or fellows    19 (51.4)    3 (17.6) -
Pharmacists      5 (13.5)    4 (23.5) -
Dieticians    2 (5.4) - -
Clinical psychologists    1 (2.7)    2 (11.8) -
Others‡      5 (13.5) - -
Values are presented as n (%).
*Multiple answers were allowed; †Others include center (treatment room) for 
atopic dermatitis and asthma for individual-level education, as well as hospi-
tal auditorium and patient ward for group-level education; ‡Others include 
cases wherein the clinician, primary investigator, or specialized nurses provid-
ed the education.
Table 1. Characteristics of Participants
Variables Number of participants (n, %)
Field of specialization
Dermatology   44 (28.8)
Allergy/pediatric allergy 109 (71.2)
Medical institution
Primary clinic   39 (25.5)
Children’s hospital     9 (5.9)
Secondary hospital   22 (14.4)
University hospital   82 (53.6)
No response     1 (0.6)
Consultation/treatment time per patient
≤5 min   14 (9.2)
6–10 min   56 (36.6)
11–20 min   55 (35.9)
21–30 min   28 (18.3)
31–60 min     0 (0)
More than 1 hr     0 (0)
Values are presented as n (%).
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quently involved (23 participants), followed by residents or 
fellows (19), dieticians (five), pharmacists (two), and clinical 
psychologists (one). Similar results were found for group-level 
programs.
We then assessed the frequency of education (Fig. 1). For the 
centers that provided an individual-level program, 23 of 37 
centers (62.2%) provided the program only at the time of ini-
tial diagnosis, and nine centers (24.3%) provided the program 
during every consultation. While some (13.5%) provided edu-
cation one to three times annually, no center provided educa-
tion more than four times a year. Regarding group-level educa-
tion, among the eight centers, five (62.5%) provided education 
≤six times per year; two centers, more than seven times per 
year; and one center provided education as needed. Individu-
al- and group-level educational programs were provided for 
both the patients and their caregivers in 97.3% and 100% of the 
centers, respectively. In most cases (97.6%), no extra costs were 
charged for additional education.
The survey also inquired about the topics covered. Details are 
shown in Fig. 2. Regarding the natural course of the disease, all 
centers addressed its chronicity. Among the 41 responders, 38 
(92.7%) reported that the education included disease charac-
teristics of each age group, and 36 (87.8%) reported that the 
associations with other allergic diseases were also included. 
For daily skin care, more than 92.7% of the responders said 
they covered topics such as lukewarm baths, moisturizer use, 
and coping with the urge to scratch. 
Regarding the use of medications, 31 of 41 (75.6%) responders 
stated that proper application of topical ointments was shown 
through demonstration. Similarly, 24 responders (58.5%) stated 
that education covered wet-wrap therapy, in which 41.7% were 
pediatricians/allergists and 58.3% were dermatologists. Of the 
41 participants, 36 (87.8%) responded that they covered prop-
er ointment use upon symptomatic exacerbations. These in-
dicate a relatively lower rate of detailed instructions on medica-
tion use. For the management of environmental and aggravating 
factors, 39 (95.1%) responders stated that the programs covered 
temperature and humidity management, 34 (83%) reported 
the benefits of wearing cotton-based clothing, and 35 (85.4%) 
reported the control of exposure to common allergens.
Regarding diet, only 20 responders (48.8%) said they had 
surveyed patients’ diets. Thirty-seven (90.2%) indicated that 
they advised elimination of food that exacerbate symptoms, 
and 29 (70.7%) said the programs included education on al-
ternative foods. Most responders (92.7%) advised against un-
warranted dietary restrictions. In terms of nutritional counsel-
ing, in contrast to 27.3% of dermatologists, 73.3% of allergists 
said they understood the patients’ nutritional status. Mean-
while, only nine (22%) provided psychologic counseling.
We also assessed the sources of data used for the programs, 
and multiple answers were allowed. Thirty-three (80.5%) re-
sponders stated that they developed their own educational 
materials. Eighteen participants utilized materials from aca-
demic societies or associations. Oral presentation was the main 
delivery method (35 participants), followed by handouts (32 
participants) and video-based information (11 participants). 
Four participants used other methods, including information 
panels, tools, and presentation slides. Objective indices, such 
as Eczema Area Severity Index (EASI) and SCORing Atopic 
Dermatitis (SCORAD), were used by 41.5% of the responders. 
For 109 participants who did not provide the educational 
program, 58 out of 90 participants (64.4%) preferred individu-
al-level education, whereas only 10 participants (11.1%) pre-
ferred group-level education. The remaining 24.4% of the partic-
ipants indicated that both educational programs were required.
Overall, 96.7% of the participants said an additional charge 
was needed for education on AD. Furthermore, they men-
tioned that additional assistance from an academic society or 
association, in the form of medical staff, organized data, and 
advertisement, was required to provide a well-structured edu-
cational program. Eighty-seven out of 90 participants (96.7%) 
were willing to provide education for patients with AD if an ap-
propriate consultation fee was provided. Therefore, with an ad-
ditional budget for education on AD, more patients will surely 
benefit.
According to the results, only 26.8% of the centers sched-
uled additional time aside from the clinics to provide an ap-
propriate education. Most of them were university hospitals, 
likely due to the smaller number of clinicians from private clin-
1 time/year or less
1 (12.5%)
1–6 times/year
4 (50%)
7–12 times/year
1 (12.5%)
On demand
1 (12.5%)
More than 
12 times/year 
1 (12.5%)
Group education
For the first visit
23 (62.2%)
Every visit
9 (24.3%)
1–3 times/year
5 (13.5%)
Individual education
A
B
Fig. 1. Frequency of (A) individual- and (B) group-level education.
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ics in this study and greater academic interest in patient edu-
cation in university hospitals. Most participants provided in-
dividual-level education, held mostly at an outpatient clinic. 
There was only one case where a dedicated venue for patient 
education was available, reflecting the scarcity of appropriate 
venues. Nurses primarily comprised most of the workforce in-
volved in the programs. 
Even if a separate education was provided, it was usually per-
formed only at the initial visit. Similarly, for group-level educa-
tion, most centers provided only six sessions or less per year. 
The appropriate management of chronic conditions requires 
continuous and repetitive patient education.12,13 However, ed-
ucation was not up to these standards in real clinical settings. 
Furthermore, more than one-third of the respondents reported 
that the average consultation time for each patient was 5–10 
min, and no one spent longer than 30 min per patient. Mean-
while, the majority indicated that education should last for lon-
ger than 15 min, some even suggesting that education should 
be 30 min or longer. Therefore, although clinicians realize the 
need for additional time for education, it may be difficult to 
achieve under the current circumstances.
Regarding the education method, oral communication and 
handouts were most commonly utilized. Indeed, audio-visual 
materials can significantly improve patient understanding,14,15 
but most centers used self-developed handouts. Therefore, a 
unified and reliable educational material must be developed.
The educational programs sought to thoroughly explain var-
ious aspects of the disease and its management. However, not 
many programs included information on the application of 
ointment, diet, or psychological aspects. Daily skin care is im-
Fig. 2. Detailed educational contents included in the programs.
Chronic course
Age-specific symptom characteristics
Association with other allergic diseases
Bathing practices
Use of moisturizers
How to deal with pruritus and scratch
Demonstration of the use of topical agents
Wet wrap therapy
Use of topical therapies
Temperature and humidity control
Choice of clothing (cotton)
Avoidance of potential allergens
Check for nutritional status
Avoidance of symptom-aggravating food
Education of alternative food
Avoidance of arbitrary diets
Psychology consultation
0  10  20  30                   40  50
19 (46.3%)
19 (46.3%)
19 (46.3%)
18 (43.9%)
18 (43.9%)
10 (24.4%)
18 (43.9%)
19 (46.3%)
17 (41.5%)
18 (43.9%)
18 (43.9%)
18 (43.9%)
18 (43.9%)
6 (14.6%)
14 (34.1%)
19 (46.3%)
17 (41.5%)
22 (53.7%)
20 (48.8%)
20 (48.8%)
20 (48.8%)
13 (31.7%)
14 (34.1%)
18 (43.9%)
20 (48.8%)
17 (41.5%)
17 (41.5%)
19 (46.3%)
11 (26.8%)
20 (48.8%)
3 (7.3%)
6 (14.6%)
19 (46.3%)
19 (46.3%)
  Pediatric allergists/allergists      Dermatologists
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portant, and direct or video demonstration would be more ef-
fective in providing adequate education for bathing and skin 
care.16 It is well-known that topical therapy is fundamental; 
however, it should be adjusted according to the patient’s con-
ditions. Furthermore, due to the lack of understanding among 
caregivers, most of them seek dietary therapy to cope with AD. 
A survey-based study17 showed that about 43% of the respond-
ers indicated dietary management to be most important, and 
more than half of the patients previously had tried dietary re-
striction. Dietary restrictions must be made only with con-
firmed food allergy,18 and when needed, education on alterna-
tive nutrition is important to prevent malnutrition. Therefore, 
dieticians must also be involved in the education.19 
The deleterious effect of psychological stress in AD has been 
well-recognized. AD results in social intimidation and reduced 
quality of life.20,21 Furthermore, psychological comorbidities, 
including anxiety and depression, are more prevalent in pa-
tients with AD.22 Stress then worsens the condition, leading to 
a vicious cycle. Also, psychological intervention and behav-
ioral therapy against itch and scratching have been reported 
to improve the condition.23,24 In summary, treatment of AD 
needs to be supported by an educational program consisting of 
a team of different professionals, including dermatologists, pe-
diatric allergists, nurses, psychological clinicians, and dieticians, 
and should endeavor towards a multidisciplinary approach.25 
Most of the clinicians who participated in this study asserted 
a need for an additional consultation fee for the education of 
AD, as a more proper type of education can be provided after 
the arrangement. Several issues, including limited time and 
inadequate medical staff, reportedly prevented clinicians from 
actively providing appropriate education in Korea. Through 
recognition of such needs, an appropriate consultation fee has 
already been adjusted for several chronic diseases, including 
diabetes, asthma, and cardiovascular disease, in Korea. Since 
AD is also a chronic disease with high prevalence, patients 
with AD would surely benefit from the education.26 
In Korea, five different municipal governments have estab-
lished educational and informational centers for AD and asth-
ma. However, additional manpower and time are needed to 
properly carry out the programs, and a more tailored protocol 
according to the patient’s age or severity is required.27-29 As the 
importance of education in AD is emphasized, structured edu-
cational programs are being provided globally, especially in 
Europe and the United States, which are supported and fund-
ed by various organizations.30,31 Likewise, the arrangement of 
education fees will lead to the establishment of a structured 
educational program with additional medical staff in Korea.
Due to the small sample size, low response rate, and possi-
ble selection bias associated with the survey, the results do 
not fully represent all clinicians who manage patients with 
AD. Therefore, a multi-center study involving a larger number 
of clinicians should be performed in the future. We hope that 
our data will be used as baseline data for the future develop-
ment of standardized education and consultation protocol for 
patients with AD.
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